a stent comprising stent struts of a biodegradable polymer material , drug depots having at least one drug in the stent struts , at least one drug that treats the consequences of degradation of the stent struts and sheathing of the drug depots that varies over time , such that the drug delivery from the drug from the drug depots is timed to coordinate with the mass degradation of the biodegradable polymer material of the stent struts .